Aurora, CO 的 白血病 臨床試驗
10 項針對 白血病 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中觀察性研究
- Children's Hospital Colorado, Aurora
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- University of Colorado, Aurora
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
招募中1 期
- Children's Hospital Colorado, Aurora
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Colorado, Aurora
Shwachman Diamond Syndrome Registry and Study
招募中觀察性研究
- Children's Hospital Colorado, Aurora
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- University of Colorado, Aurora
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
招募中觀察性研究
- Children's Hospital Colorado, Aurora
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
招募中1 期
- University of Colorado Hospital, Aurora
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Rocky Mountain Cancer Centers, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Aurora
其他城市的 白血病 試驗
- Houston, TX28 項研究
- Boston, MA25 項研究
- New York City, NY19 項研究
- Los Angeles, CA16 項研究
- Chicago, IL16 項研究
- Durham, NC13 項研究
- Baldwin Park, CA12 項研究
- Columbus, OH12 項研究
- Nashville, TN12 項研究
- Philadelphia, PA12 項研究
- Milwaukee, WI11 項研究
- Atlanta, GA11 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌30 項研究
- 乳癌27 項研究
- 轉移性癌症25 項研究
- 卵巢癌25 項研究
- 第一型糖尿病23 項研究
- 肥胖症21 項研究
- 肺癌19 項研究
- 前列腺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。